Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001048396 | SCV001212397 | uncertain significance | Familial cold autoinflammatory syndrome 3 | 2023-07-25 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with PLCG2-related conditions. This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 1217 of the PLCG2 protein (p.Tyr1217Cys). This variant is present in population databases (rs373013824, gnomAD 0.004%). ClinVar contains an entry for this variant (Variation ID: 845350). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV002261261 | SCV002541341 | uncertain significance | not provided | 2021-11-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002481941 | SCV002791537 | uncertain significance | Familial cold autoinflammatory syndrome 3; Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation | 2021-12-15 | criteria provided, single submitter | clinical testing |